Furthermore, mining the public Oncomine lung cancer datasets revealed that the expression levels of both LH2 and LH3 were upregulated in lung adenocarcinomas compared to normal lung tissues (Table 2), supporting the notion that these LHs may be useful targets for developing strategies for treating lung cancer. The gene discussed is PLOD2; the disease is lung carcinoma.